{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:25:04Z","timestamp":1789903504964,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cimid.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T16:26:06Z","timestamp":1536942366000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Vaccination against Toxoplasma gondii using rhoptry antigens: a systematic review"],"prefix":"10.1016","volume":"59","author":[{"given":"Roghiyeh","family":"Faridnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Daryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahabeddin","family":"Sarvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cimid.2018.09.005_bib0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ijpara.2009.01.005","article-title":"History of the discovery of the life cycle of Toxoplasma gondii","volume":"39","author":"Dubey","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0010","first-page":"389","article-title":"Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pt.2016.10.007","article-title":"Lifelong persistence of Toxoplasma cysts: a questionable dogma?","volume":"33","author":"Rougier","year":"2017","journal-title":"Trend. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0025","first-page":"794","article-title":"Downregulation of IL-10R1 and IL-10R2: a possible strategy by which the intermediate host struggles to control Toxoplasma gondii infection","volume":"7","author":"Pestechian","year":"2016","journal-title":"Int. J. Adv. Biotechnol. Res."},{"key":"10.1016\/j.cimid.2018.09.005_bib0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fimmu.2018.00158","article-title":"Characteristics of infection immunity regulated by Toxoplasma gondii to maintain chronic infection in the brain","volume":"9","author":"Hwang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0035","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1586\/14760584.2015.1098539","article-title":"Recent advances in developing vaccines against Toxoplasma gondii: an update","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert. Rev. Vaccines."},{"key":"10.1016\/j.cimid.2018.09.005_bib0040","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.9525","article-title":"Electrophoretic patterns of Toxoplasma gondii excreted\/secreted antigens and their role in induction of the humoral immune response","volume":"7","author":"Daryani","year":"2014","journal-title":"Jundishapur. J. Microbiol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0045","first-page":"410","article-title":"Manipulation of IL-10 gene expression by Toxoplasma gondii and its products","volume":"30","author":"Pestechian","year":"2016","journal-title":"Med. J. Islam. Repub. Iran."},{"key":"10.1016\/j.cimid.2018.09.005_bib0050","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1462-5822.2007.00909.x","article-title":"Rhoptries are major players in Toxoplasma gondii invasion and host cell interaction","volume":"9","author":"Dubremetz","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0055","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1128\/IAI.01447-07","article-title":"Toxoplasma gondii rhoptry discharge correlates with activation of the early growth response 2 host cell transcription factor","volume":"76","author":"Phelps","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cimid.2018.09.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/632424","article-title":"Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis","volume":"2008","author":"Dlugonska","year":"2008","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcms.2010.11.001","article-title":"Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias","volume":"39","author":"Knobloch","year":"2011","journal-title":"J. Cranio. Maxill Sur."},{"key":"10.1016\/j.cimid.2018.09.005_bib0070","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1016\/j.vaccine.2015.10.077","article-title":"Toxoplasma gondii: vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice","volume":"33","author":"Cao","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2018.09.005_bib0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14760584.2015.1011133","article-title":"DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice","volume":"14","author":"Chen","year":"2015","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1016\/j.cimid.2018.09.005_bib0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.exppara.2014.02.016","article-title":"Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis","volume":"139","author":"Chen","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.exppara.2009.06.002","article-title":"Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis","volume":"123","author":"Dziadek","year":"2009","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0090","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1016\/j.vaccine.2006.02.039","article-title":"Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein","volume":"24","author":"Echeverria","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2018.09.005_bib0095","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.5897\/AJB10.1860","article-title":"Induction of protective immunity against toxoplasmosis in mice by immunization with a plasmid encoding Toxoplama gondii ROP1 gene","volume":"11","author":"Eslamirad","year":"2012","journal-title":"Afr. J. Biotechnol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.vetpar.2011.06.010","article-title":"Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154","volume":"183","author":"Hiszczynska-Sawicka","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0105","first-page":"317","article-title":"Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-gamma against Toxoplasma gondii in mice","volume":"114","author":"Guo","year":"2001","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.cimid.2018.09.005_bib0110","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.vaccine.2010.11.012","article-title":"Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis","volume":"29","author":"Hoseinian Khosroshahi","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2018.09.005_bib0115","first-page":"25","article-title":"Evaluation of immunization of BALB\/c mice by plasmid encoding complete ROP2 gene of Toxoplasma gondii","volume":"13","author":"Hoseinian Khosroshahi","year":"2010","journal-title":"Modares. J. Med. Sci. Pathobiol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.exppara.2007.10.002","article-title":"Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB\/c mice","volume":"118","author":"Igarashi","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1365-2249.1997.4891384.x","article-title":"Antagonistic effects of IL-4 and interferon-gamma (IFN-gamma) on inducible nitric oxide synthase expression in bovine macrophages exposed to gram-positive bacteria","volume":"109","author":"Jungi","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s004360000296","article-title":"Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii","volume":"87","author":"Leyva","year":"2001","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cimid.2018.09.005_bib0135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-3024.2010.01228.x","article-title":"Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes","volume":"32","author":"Li","year":"2010","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00436-011-2296-5","article-title":"Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses","volume":"109","author":"Li","year":"2011","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cimid.2018.09.005_bib0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.meegid.2016.10.006","article-title":"Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice","volume":"45","author":"Li","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/hv.26703","article-title":"Toxoplasma gondii: immune response and protective efficacy induced by ROP16\/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2","volume":"10","author":"Liu","year":"2014","journal-title":"Hum., Vaccin Immunother."},{"key":"10.1016\/j.cimid.2018.09.005_bib0155","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12879-015-0815-1","article-title":"Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice","volume":"15","author":"Li","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cimid.2018.09.005_bib0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s004360100429","article-title":"Recombinant feline herpesvirus type 1 expressing Toxoplasma gondi ROP2 antigen inducible protective immunity in cats","volume":"88","author":"Mishima","year":"2002","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cimid.2018.09.005_bib0165","first-page":"590","article-title":"Evaluation of immunogenicity of cocktail DNA vaccine containing plasmids encoding complete GRA5, SAG1, and ROP2 antigens of Toxoplasma gondii in BALB\/C mice","volume":"10","author":"Naserifar","year":"2015","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0170","first-page":"56","article-title":"Partial immunity in murine by vaccination with a toxoplasmic DNA antibody","volume":"2","author":"Pedrad","year":"2015","journal-title":"Int. J. Vac. Immun."},{"key":"10.1016\/j.cimid.2018.09.005_bib0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.exppara.2013.07.013","article-title":"Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re","volume":"135","author":"Qu","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0180","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1007\/s00436-013-3425-0","article-title":"Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice","volume":"112","author":"Qu","year":"2013","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cimid.2018.09.005_bib0185","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1016\/j.vaccine.2011.09.099","article-title":"Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis","volume":"29","author":"Rashid","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2018.09.005_bib0190","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4269\/ajtmh.12-0727","article-title":"Protective immune response in BALB\/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii","volume":"88","author":"Parthasarathy","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.cimid.2018.09.005_bib0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00430-016-0483-9","article-title":"Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route","volume":"206","author":"Rashid","year":"2017","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S0031182003004761","article-title":"MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis","volume":"128","author":"Roque-Resendiz","year":"2004","journal-title":"Parasitology"},{"key":"10.1016\/j.cimid.2018.09.005_bib0205","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.exppara.2011.04.004","article-title":"Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection","volume":"128","author":"Sanchez","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0210","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3389\/fmicb.2016.00808","article-title":"Induction of protective immunity against toxoplasmosis in BALB\/c mice vaccinated with Toxoplasma gondii Rhoptry-1","volume":"7","author":"Sonaimuthu","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.parint.2007.04.003","article-title":"Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii","volume":"56","author":"Wang","year":"2007","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.cimid.2018.09.005_bib0220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1051\/parasite\/2016004","article-title":"DNA vaccination with a gene encoding Toxoplasma gondii rhoptry protein 17 induces partial protective immunity against lethal challenge in mice","volume":"23","author":"Wang","year":"2016","journal-title":"Parasite"},{"key":"10.1016\/j.cimid.2018.09.005_bib0225","article-title":"Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cimid.2018.09.005_bib0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/pim.12306","article-title":"Evaluation of immune responses induced by rhoptry protein 5 and rhoptry protein 7 DNA vaccines against Toxoplasma gondii","volume":"38","author":"Wang","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0235","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1128\/CVI.00397-12","article-title":"Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice","volume":"19","author":"Wang","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1051\/parasite\/2017013","article-title":"Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes","volume":"24","author":"Wang","year":"2017","journal-title":"Parasite"},{"key":"10.1016\/j.cimid.2018.09.005_bib0245","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.parint.2008.05.001","article-title":"Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii","volume":"57","author":"Xue","year":"2008","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.cimid.2018.09.005_bib0250","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/1471-2334-14-525","article-title":"Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model","volume":"14","author":"Xu","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cimid.2018.09.005_bib0255","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/s13071-015-1108-7","article-title":"A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB\/c mice against parasite infection","volume":"8","author":"Yin","year":"2015","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.cimid.2018.09.005_bib0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CVI.00312-10","article-title":"Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice","volume":"18","author":"Yuan","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0265","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2011.06.110","article-title":"Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18","volume":"29","author":"Yuan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2018.09.005_bib0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00436-007-0465-3","article-title":"Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB\/c mice","volume":"101","author":"Zhang","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cimid.2018.09.005_bib0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exppara.2016.01.011","article-title":"Protective efficacy of pVAX-RON5p against acute and chronic infections of Toxoplasma gondii in BALB\/c mice","volume":"163","author":"Zhao","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0280","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1016\/j.vaccine.2013.07.058","article-title":"The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice","volume":"31","author":"Zheng","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2018.09.005_bib0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1051\/parasite\/2016017","article-title":"Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii","volume":"23","author":"Zhou","year":"2016","journal-title":"Parasite"},{"key":"10.1016\/j.cimid.2018.09.005_bib0290","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.exppara.2012.02.026","article-title":"Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB\/c mice","volume":"131","author":"Dziadek","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0295","series-title":"Vaccine Adjuvants: Preparation Methods and Research Protocols","first-page":"49","article-title":"Freund\u2019s adjuvants","author":"Lindblad","year":"2000"},{"key":"10.1016\/j.cimid.2018.09.005_bib0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002007","article-title":"The moving junction protein RON8 facilitates firm attachment and host cell invasion in Toxoplasma gondii","volume":"7","author":"Straub","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cimid.2018.09.005_bib0305","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0310","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.vaccine.2005.10.046","article-title":"Low-dose intraperitoneal Freund\u2019s adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-\u03b2 peptide","volume":"24","author":"Oscherwitz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2018.09.005_bib0315","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF03402065","article-title":"Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates","volume":"5","author":"McCluskie","year":"1999","journal-title":"Mol. Med."},{"key":"10.1016\/j.cimid.2018.09.005_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4017(97)00227-6","article-title":"Toxoplasmosis of rats: a review, with considerations of their value as an animal model and their possible role in epidemiology","volume":"77","author":"Dubey","year":"1998","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1051\/parasite\/200411189","article-title":"Immune responses of different mouse strains after challenge with equivalent lethal doses of Toxoplasma gondii","volume":"11","author":"Lee","year":"2004","journal-title":"Parasite"},{"key":"10.1016\/j.cimid.2018.09.005_bib0330","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7883\/yoken1952.36.343","article-title":"Species and strain differences in sensitivity to Toxoplasma infection among laboratory rodents","volume":"36","author":"Fujii","year":"1983","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"10.1016\/j.cimid.2018.09.005_bib0335","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1469-0691.2002.00485.x","article-title":"Toxoplasma gondii: transmission, diagnosis and prevention","volume":"8","author":"Hill","year":"2002","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cimid.2018.09.005_bib0340","series-title":"Toxoplasmosis: a Comprehensive Clinical Guide","first-page":"296","article-title":"Laboratory diagnosis of Toxoplasma infection","author":"Joynson","year":"2001"},{"key":"10.1016\/j.cimid.2018.09.005_bib0345","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/14712598.2018.1413086","article-title":"Moving towards improved vaccines for Toxoplasma gondii","volume":"18","author":"Li","year":"2018","journal-title":"Exp. Opin. Biol. Ther."}],"container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957118300626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957118300626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T03:58:22Z","timestamp":1693886302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147957118300626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":69,"alternative-id":["S0147957118300626"],"URL":"https:\/\/doi.org\/10.1016\/j.cimid.2018.09.005","relation":{},"ISSN":["0147-9571"],"issn-type":[{"value":"0147-9571","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination against Toxoplasma gondii using rhoptry antigens: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Comparative Immunology, Microbiology and Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cimid.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}